Skip to main content
Equibles

SHREEGANES · Shree Ganesh Biotech (India) L · Financials

Use SHREEGANES with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SHREEGANES.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
0.45 INR -0.02 (-4.26%) At close · Nov 13
Rebalance outlook locked
Market Cap
179.38M INR
Shares
398.62M
Volume · Nov 13 341.59K Avg daily vol (3M) 580.62K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
49.71M -78.3%
FY2026 Revenue FY2025–FY2026
Net Income
3.78M +35.7%
FY2026 Net Income FY2025–FY2026
Operating Cash Flow
-81.96M +19.7%
FY2026 Operating Cash Flow FY2025–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026 FY2025
INR 44.09M 49.71M 229.58M
INR 5000 5000 5000
INR 0 0 0
INR -4.81M 5.14M 3.87M
INR 0 1.37M 1.09M
INR -4.81M 3.78M 2.78M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2025–FY2026: 0 in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.